These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10838448)

  • 1. Epsilon-aminocaproic acid inhibits the activity of factor VIII inhibitors in patients with severe haemophilia A in vivo and in vitro.
    Ghosh K; Shetty S; Pathare A; Mohanty D
    Acta Haematol; 2000; 103(2):67-72. PubMed ID: 10838448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of epsilon amino caproic acid in the management of haemophilic patients with inhibitors.
    Ghosh K; Shetty S; Jijina F; Mohanty D
    Haemophilia; 2004 Jan; 10(1):58-62. PubMed ID: 14962221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: successful use of antifibrinolytic therapy in acquired factor VIII deficiency.
    Lalwani RB; Stricker RB
    Am J Med Sci; 1992 Jun; 303(6):398-401. PubMed ID: 1605170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of factor VIII inhibitors: evolution and current status.
    Bloom AL
    Haemostasis; 1992; 22(5):268-75. PubMed ID: 1478538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial plasmin activity with epsilon aminocaproic acid: temporal and regional heterogeneity.
    Reust DL; Reeves ST; Abernathy JH; Dixon JA; Gaillard WF; Mukherjee R; Koval CN; Stroud RE; Spinale FG
    Ann Thorac Surg; 2010 May; 89(5):1538-45. PubMed ID: 20417774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostasis in acquired hemophilia--role of intracavitary instillation of EACA.
    Sahu S; Raipancholia R; Pardiwalla FK; Pathare AV
    J Postgrad Med; 1996; 42(3):88-90. PubMed ID: 9715327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EFFECT OF ε-AMINOCAPROIC ACID ON FIBRINOLYSIS IN PLASMA OF ASIAN ELEPHANTS (ELEPHAS MAXIMUS).
    Kaye S; Abou-Madi N; Fletcher DJ
    J Zoo Wildl Med; 2016 Jun; 47(2):397-404. PubMed ID: 27468009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
    Collins PW; Chalmers E; Hart DP; Liesner R; Rangarajan S; Talks K; Williams M; Hay CR;
    Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low-dose 'factor VIII inhibitor bypassing activity (FEIBA)' in resistant haemophilia.
    Zwahlen H; Beck EA
    Acta Haematol; 1980; 64(1):12-7. PubMed ID: 6774572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis.
    Giles AR; Verbruggen B; Rivard GE; Teitel J; Walker I
    Thromb Haemost; 1998 Apr; 79(4):872-5. PubMed ID: 9569207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
    Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
    Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected higher blood loss associated with higher dose ε-aminocaproic acid in pediatric scoliosis surgery.
    Lam H; Austin T; Nguyen T; Martus J; Schoenecker J
    J Pediatr Orthop B; 2019 Jan; 28(1):40-44. PubMed ID: 30199414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lingual hemorrhage in a patient with hemophilia A complicated by a high titer inhibitor. Management by continuous infusion of monoclonal antibody-purified factor VIII.
    Gordon EM; Mungo R; Goldsmith JC
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):107-10. PubMed ID: 8447550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory investigation of the effects of epsilon-aminocaproic acid on hemostasis.
    Green D; Ts'ao CH; Cerullo L; Cohen I; Ruo TI; Atkinson AJ
    J Lab Clin Med; 1985 Mar; 105(3):321-7. PubMed ID: 2982982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma proteinase inhibitor activity and hemostasis tests in children with nephrotic syndrome. Effect of prednisone alone and prednisone plus epsilon-aminocaproic acid treatment regimens: a preliminary report.
    Prandota J; Pankow-Prandota L; Kotecki L; Noga L
    Am J Ther; 2001; 8(2):97-107. PubMed ID: 11304663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
    Ozelo MC; Svirin P; Larina L
    Ann Hematol; 2005 Nov; 84(12):816-22. PubMed ID: 16044315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-factor-VIII inhibitors in haemophilia.
    Lancet; 1989 Aug; 2(8659):363-4. PubMed ID: 2569554
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party.
    Hay CR; Ollier W; Pepper L; Cumming A; Keeney S; Goodeve AC; Colvin BT; Hill FG; Preston FE; Peake IR
    Thromb Haemost; 1997 Feb; 77(2):234-7. PubMed ID: 9157572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of some epsilon-aminocaproic acid derivatives on platelet responses.
    Bruzgo I; Tomasiak M; Stelmach H; Midura-Nowaczek K
    Acta Biochim Pol; 2004; 51(1):73-80. PubMed ID: 15094827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.